MX2016011517A - Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico. - Google Patents
Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.Info
- Publication number
- MX2016011517A MX2016011517A MX2016011517A MX2016011517A MX2016011517A MX 2016011517 A MX2016011517 A MX 2016011517A MX 2016011517 A MX2016011517 A MX 2016011517A MX 2016011517 A MX2016011517 A MX 2016011517A MX 2016011517 A MX2016011517 A MX 2016011517A
- Authority
- MX
- Mexico
- Prior art keywords
- crmp2
- disclosed
- chronic pain
- narcotic
- sodium channels
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
En la presente se divulgan polipéptidos aislados capaces de prevenir el tráfico mediado por (SUMO) ilación de modificador tipo ubiquitina pequeño-proteína 2 mediadora de respuesta colapsante (CRMP2) de la función del canal de sodio cerrado al voltaje (Nav1.7). En algunos ejemplos, los péptidos divulgados comprenden tres a veinte aminoácidos e incluyen la secuencia de aminoácidos KMD. Igualmente se divulgan métodos para disminuir la nocicepción, que incluyen administrar una cantidad efectiva de uno o más de los péptidos divulgados a un sujeto en necesidad de ello, tal como un sujeto que experimenta dolor crónico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461949456P | 2014-03-07 | 2014-03-07 | |
PCT/US2015/019275 WO2015134920A1 (en) | 2014-03-07 | 2015-03-06 | Non-narcotic crmp2 peptides targeting sodium channels for chronic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016011517A true MX2016011517A (es) | 2017-04-13 |
Family
ID=54055921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016011517A MX2016011517A (es) | 2014-03-07 | 2015-03-06 | Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico. |
Country Status (7)
Country | Link |
---|---|
US (1) | US10287334B2 (es) |
EP (1) | EP3119415A4 (es) |
JP (1) | JP6625071B2 (es) |
AU (1) | AU2015226911B2 (es) |
CA (1) | CA2941357A1 (es) |
MX (1) | MX2016011517A (es) |
WO (1) | WO2015134920A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10202007103TA (en) | 2014-11-05 | 2020-09-29 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
CA2975583A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
US10456475B2 (en) | 2015-02-03 | 2019-10-29 | Kennsaw State University Research and Service Foundation, Inc. | Cell penetrating protein adaptor molecules and their application in research and medicine |
US10435446B2 (en) | 2015-06-03 | 2019-10-08 | Kennesaw State University Research and Service Foundation Inc. | Cell penetrating protein adaptor molecules and their application in research and medicine |
CA3090492C (en) | 2015-10-07 | 2023-02-14 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Crmp2 sumoylation inhibitors and uses thereof |
US10654894B2 (en) | 2016-02-03 | 2020-05-19 | Keenesaw State University Research And Service Foundation, Inc. | Methods for delivering cargo into a cell by using signal molecules as cell penetration agents |
CA3024448A1 (en) | 2016-05-18 | 2017-11-23 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
EP3576734A4 (en) * | 2017-02-03 | 2020-12-09 | Arizona Board of Regents on behalf of the University of Arizona | SMALL MOLECULE ANTAGONISTS OF THE SUMO-RELATED MODIFICATION OF CRMP2 AND THEIR USES |
JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
KR102072563B1 (ko) * | 2018-06-27 | 2020-02-03 | 가톨릭대학교 산학협력단 | Dpysl2를 포함하는 인터넷 게임 장애 진단용 바이오마커 및 그의 용도 |
US20220110851A1 (en) * | 2018-12-26 | 2022-04-14 | Skinmed Co., Ltd. | Acetylcholine receptor inhibitory peptides and uses thereof |
US11219629B2 (en) | 2019-10-17 | 2022-01-11 | Hooman M. MELAMED | Anesthetic pharmaceutical composition, system and method |
CN113214362B (zh) * | 2021-05-18 | 2022-06-21 | 湖南百尔泰克化妆品有限公司 | 一种对钠通道有抑制作用的多肽及其应用 |
WO2022264184A1 (en) * | 2021-06-17 | 2022-12-22 | The University Of Jordan | Ophthalmic nano-dispersion composition, a method of preparation thereof, and formulation for corneal epithelial wound healing |
WO2024011119A2 (en) * | 2022-07-06 | 2024-01-11 | The Regents Of The University Of California | Peptides targeting sodium channels to treat pain |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4886499A (en) | 1986-12-18 | 1989-12-12 | Hoffmann-La Roche Inc. | Portable injection appliance |
GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
CA2031376A1 (en) | 1989-12-04 | 1991-06-05 | Bahram Farhadieh | Single layer transdermal drug administration system |
US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
JPH07502219A (ja) | 1991-12-18 | 1995-03-09 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 多重層型バリアー構造体 |
EP0553769B1 (de) | 1992-01-29 | 1996-01-03 | FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG | Ballspielschläger, insbesondere Tennisschläger |
US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
KR100201352B1 (ko) | 1995-03-16 | 1999-06-15 | 성재갑 | 단일주사 백신 제형 |
US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
US6673574B2 (en) | 2000-11-30 | 2004-01-06 | Unigene Laboratories Inc. | Oral delivery of peptides using enzyme-cleavable membrane translocators |
AU2002240201A1 (en) * | 2001-02-02 | 2002-08-19 | Yale University | Peptides for facilitating composite receptor expression and translocation of macromolecules |
US7081489B2 (en) | 2001-08-09 | 2006-07-25 | Florida State University Research Foundation | Polymeric encapsulation of nanoparticles |
US6780324B2 (en) | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
EP1583473A2 (en) | 2003-01-16 | 2005-10-12 | St. Johns University New York | Nanoparticle based stabilization of ir fluorescent dyes |
WO2006052285A2 (en) | 2004-05-13 | 2006-05-18 | The Trustees Of Columbia University In The City Of New York | Polymeric nanoparticles and nanogels for extraction and release of compounds |
ATE382337T1 (de) | 2005-04-28 | 2008-01-15 | Nipro Corp | Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer |
AU2006244135A1 (en) | 2005-05-10 | 2006-11-16 | Naomi Balaban | Compositions for administering RNAIII-inhibiting peptides |
US20060275321A1 (en) * | 2005-06-01 | 2006-12-07 | Phoenix Pharmaceuticals, Inc. | Polypeptide antagonists of HIV-1 Tat protein |
GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
US8980843B2 (en) * | 2009-07-01 | 2015-03-17 | Temple University—Of the Commonwealth System of Higher Education | Leptin agonist and methods of use |
-
2015
- 2015-03-06 EP EP15758648.8A patent/EP3119415A4/en not_active Withdrawn
- 2015-03-06 MX MX2016011517A patent/MX2016011517A/es unknown
- 2015-03-06 AU AU2015226911A patent/AU2015226911B2/en active Active
- 2015-03-06 CA CA2941357A patent/CA2941357A1/en active Pending
- 2015-03-06 JP JP2016573711A patent/JP6625071B2/ja active Active
- 2015-03-06 US US15/124,304 patent/US10287334B2/en active Active
- 2015-03-06 WO PCT/US2015/019275 patent/WO2015134920A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2017515496A (ja) | 2017-06-15 |
CA2941357A1 (en) | 2015-09-11 |
WO2015134920A1 (en) | 2015-09-11 |
AU2015226911A1 (en) | 2016-10-27 |
US20170008939A1 (en) | 2017-01-12 |
EP3119415A1 (en) | 2017-01-25 |
US10287334B2 (en) | 2019-05-14 |
EP3119415A4 (en) | 2017-11-29 |
AU2015226911B2 (en) | 2018-03-01 |
JP6625071B2 (ja) | 2019-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016011517A (es) | Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico. | |
PH12018502361A1 (en) | Gdf15 fusion proteins and uses thereof | |
MX2019006045A (es) | Proteinas triespecificas dirigidas a psma y metodos de uso. | |
MX2021006615A (es) | Proteinas de union triespecificas y metodos de uso. | |
ZA202002094B (en) | Trispecific proteins and methods of use | |
MX2018010824A (es) | Proteinas de union inducibles y metodos de uso. | |
MX2022001134A (es) | Proteinas quimericas de factor viii y usos de estas. | |
EP3788068A4 (en) | INTERLEUKIN-15 FUSION PROTEINS AND COMPOSITIONS AND THERAPEUTIC METHODS THEREOF | |
MX2022005291A (es) | Vacunas para el tratamiento y prevencion del cancer. | |
SA518390954B1 (ar) | لقاحات علاجية لفيروس الورم الحليمي البشري 18 | |
WO2015148974A3 (en) | Engineered light-activated anion channel proteins and methods of use thereof | |
MX2017010072A (es) | Moleculas multivalentes que se enlazan a cd20, las cuales comprenden regiones efectoras de la subunidad a de la toxina shiga, y composiciones enriquecidas de las mismas. | |
MX2017008817A (es) | Composiciones y metodos para la glicosilacion de proteinas. | |
WO2015048348A3 (en) | Compositions and formulations for increasing renal function and treatment and prevention of renal diseases, and methods of production and use thereof | |
WO2015188132A8 (en) | Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof | |
WO2015138357A3 (en) | Compositions useful in treatment of otc deficency | |
WO2015023891A3 (en) | Factor viii-xten fusions and uses thereof | |
WO2016046234A3 (en) | Recombinant phe-free proteins for use in the treatment of phenylketonuria | |
EP3936141A3 (en) | Anti-senescence compounds and uses thereof | |
MX2019004487A (es) | Metodos y composiciones para el tratamiento de la enfermedad de fabry. | |
NZ703597A (en) | Mutant fragments of ospa and methods and uses relating thereto | |
MX2019006515A (es) | Composiciones que comprenden peptido wkdeagkplvk. | |
WO2015161267A3 (en) | Humanized and chimeric monoclonal antibodies to cd99 | |
NZ721015A (en) | Mutant fragments of ospa and methods and uses relating thereto | |
PH12020550483A1 (en) | Anti-apoc3 antibodies and methods of use thereof |